International randomised controlled trial evaluating metabolic syndrome in type 2 diabetic cigarette smokers following switching to combustion-free nicotine delivery systems: the DIASMOKE protocol

This article has been retracted.

Saved in:
Bibliographic Details
Published inBMJ open Vol. 11; no. 4; p. e045396
Main Authors Krysinski, Arkadiusz, Russo, Cristina, John, Sarah, Belsey, Jonathan D, Campagna, Davide, Caponnetto, Pasquale, Vudu, Lorina, Lim, Chong Wei, Purrello, Francesco, Di Mauro, Maurizio, Iqbal, Farrukh, Fluck, David, Franek, Edward, Polosa, Riccardo, Sharma, Pankaj
Format Journal Article
LanguageEnglish
Published England British Medical Journal Publishing Group 27.04.2021
BMJ Publishing Group LTD
BMJ Publishing Group
SeriesProtocol
Subjects
Adult
Carbon monoxide
Cardiovascular disease
Cigarettes
Creatinine
Diabetes
Diabetes Mellitus, Type 2
Diabetic neuropathy
Electronic Nicotine Delivery Systems
Hemoglobin
Humans
Hypertension
Metabolic Syndrome
Nicotine
Patients
Questionnaires
Randomized Controlled Trials as Topic
Risk factors
Smokers
Smoking and Tobacco
Smoking cessation
Tobacco
Tobacco Products
Young Adult
general diabetes
hypertension
diabetes & endocrinology
lipid disorders
Online AccessGet full text

Cover

More Information
Summary:This article has been retracted.
Bibliography:Protocol
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Correction/Retraction-4
ObjectType-Undefined-3
ISSN:2044-6055
2044-6055
DOI:10.1136/bmjopen-2020-045396